2001
DOI: 10.1016/s0160-4120(01)00028-9
|View full text |Cite
|
Sign up to set email alerts
|

Bioanalytical screening methods for dioxins and dioxin-like compounds — a review of bioassay/biomarker technology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
134
0
3

Year Published

2005
2005
2015
2015

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 233 publications
(137 citation statements)
references
References 153 publications
0
134
0
3
Order By: Relevance
“…PCDD/F congeners with 2,3,7,8-substitution, several non-ortho and mono-ortho PCBs, as well as certain PAHs with dioxin-like structures, are found to act in a similar way through binding to the aryl hydrocarbon receptor (AhR) and inducing the CYP1A1 gene Van den Berg et al, 2006). Numerous studies have utilized in vitro bioassays based on ethoxyresorufin-O-deethylase (EROD) induction in rat hepatoma cell line H4IIE and other cell lines to evaluate the relative potencies of compounds in inducing CYP1A enzyme system (Behnisch et al, 2001a;Giesy et al, 2002;Qiao et al, 2006). This type of enzymatic assay has undergone a number of improvements since its initial stages, and has been proven to be a useful tool for characterizing complex mixtures of dioxin-like contaminants (Behnisch et al, 2001a,b;Giesy et al, 2002;Whyte et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…PCDD/F congeners with 2,3,7,8-substitution, several non-ortho and mono-ortho PCBs, as well as certain PAHs with dioxin-like structures, are found to act in a similar way through binding to the aryl hydrocarbon receptor (AhR) and inducing the CYP1A1 gene Van den Berg et al, 2006). Numerous studies have utilized in vitro bioassays based on ethoxyresorufin-O-deethylase (EROD) induction in rat hepatoma cell line H4IIE and other cell lines to evaluate the relative potencies of compounds in inducing CYP1A enzyme system (Behnisch et al, 2001a;Giesy et al, 2002;Qiao et al, 2006). This type of enzymatic assay has undergone a number of improvements since its initial stages, and has been proven to be a useful tool for characterizing complex mixtures of dioxin-like contaminants (Behnisch et al, 2001a,b;Giesy et al, 2002;Whyte et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Several in vitro bioassays have been developed for assessing AhR activity and the detection and quantification of dioxins and related chemicals [9][10][11][12]. The primary advantages of AhRbased bioassays are their high throughput capacity and low cost, compared with gas chromatography/high-resolution mass spectrometry (GC/HRMS) [12].…”
Section: Introductionmentioning
confidence: 99%
“…Table 1 gives some of the main characteristics of both screening and confirmatory approaches in early 2000, at the time the EU strategy was implemented. Specific analytical criteria had to be developed for the CALUX to be properly used in the framework of selected contaminant measurement, taking into account differences between biological equivalent (BEQ) response, based on relative potency (REP) values of the assay, and toxic equivalent (TEQ) values, based on toxic equivalent factors (TEFs) used for the setting of MRLs [19]. Additional set up of specific BEQ cut-off values was also required to improve the assignment of the "suspected non-compliant" status [20].…”
Section: How It All Startedmentioning
confidence: 99%